Quipt Home Medical Corp. has received an acquisition offer from Forager Capital Management to purchase 100% of Quipt's issued and outstanding common shares at a price of $3.10 per share. Forager, a significant shareholder in Quipt, disputes Quipt's previous characterization of the offer as "unsolicited" and emphasizes that the proposal aligns with their priority of enhancing shareholder value. The offer follows an invitation from Quipt's Chairman to Forager to access additional data and engage in the proposal process. The announcement has sparked a request from Forager for Quipt to retract its earlier statements and terminate the existing Non-Disclosure and Standstill Agreement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.